Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Financial Performance - For the quarter ended March 2024, Agilon Health reported revenue of $1.6 billion, reflecting a year-over-year increase of 41.2% [1] - The earnings per share (EPS) was $0.01, down from $0.04 in the same quarter last year [1] - The reported revenue was a slight miss of -0.85% compared to the Zacks Consensus Estimate of $1.62 billion, while the EPS exceeded the consensus estimate of -$0.02 by +150.00% [1] Key Metrics - Average Medicare Advantage membership reached 518,400, surpassing the estimated 513,855 [2] - Direct Contracting beneficiaries (ACO REACH) totaled 131,000, exceeding the average estimate of 119,150 [2] - Medicare Advantage Members were reported at 522,800, slightly below the average estimate of 527,365 [2] - Revenues from medical services were $1.60 billion, compared to the average estimate of $1.61 billion, marking a +41.1% change year over year [2] - Revenues from other operating activities were $3.16 million, significantly higher than the estimated $1.92 million, representing a +139.9% change compared to the previous year [2] Stock Performance - Agilon's shares have returned -6.8% over the past month, while the Zacks S&P 500 composite experienced a -0.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]